THERAVANCE INC. THRX (NASDAQ)

$ 6.15
12/01/2008 17:19
Sponsored by
Click here!
Change: -0.53 (-7.93%)
Volume: 416,959

Avg. Volume: 573608
P/E Ratio: 0
EPS (Annual): -1.81
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 61,530
Institutional Shareholders: 85.69%
Last: 6.15
Change: -0.53 (-7.93%)
Prev. Close: 6.68
Open: 6.37
Day's Range: 6.09 - 6.74
52wk Range: 4.32 - 26.09
Market Value: 404,470
Beta: 2.01
12-month EPS Change: 0.00%
Total Return Last 12 Months: -72.27%
Total Return Last 3 Years: -59.36%
Total Return Last 5 Years: -63.11%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on THRX

Targanta shares plummet on negative FDA panel vote

(WASHINGTON)Shares of Targanta Therapeutics Corp. plunged Thursday, a day after a panel of government experts voted against the benefits of the company's antibiotic.READ MORE
Nov 20, 2008 11:08AM
Keywords: TARG, THRX, PFE, CBST

FDA panel splits on pair of antibiotics

(COLLEGE PARK, Md.)Federal health advisers on Wednesday backed the benefits of an experimental antibiotic but rebuffed another, questioning whether it would be able to fight dangerous staph infection...READ MORE
Nov 19, 2008 7:05PM
Keywords: THRX, TARG

FDA panel: Theravance antibiotic safe, effective

(COLLEGE PARK, Md.)Federal health advisers on Wednesday said an antibiotic developed by Theravance appears safe and effective for fighting "superbug" bacteria, despite potential risks for pregnant wo...READ MORE
Nov 19, 2008 6:07PM
Keywords: THRX, PFE, CBST

Ahead of the Bell: FDA experts review antibiotics

(WASHINGTON)Federal health advisers on Wednesday will debate the merits of two experimental antibiotics designed to fight "superbug" bacteria that have grown immune to older drugs.READ MORE
Nov 19, 2008 6:18AM
Keywords: THRX, TARG

FDA notes pregnancy risks with Theravance drug

(WASHINGTON)Shares of drugmaker Theravance surged Monday on the release of a federal review of the company's experimental antibiotic, despite concerns about the product's risks to pregnant wom...READ MORE
Nov 17, 2008 7:56PM
Keywords: THRX

Top Decliner: United Therapeutics trial misses goal, shares down 33 pct

In early trading Monday, United Therapeutics Corp. (Nasdaq:UTHR) shares fell more than 30 percent on Monday after it said one of its treatments in the FREEDOM-C RIAL did not meet i...READ MORE
Nov 17, 2008 11:11AM
Keywords: UTHR, TRGT, THRX, VVUS, PXSL

FDA panel gives mixed review of J&J antibiotic

(WASHINGTON)Government experts narrowly backed a Johnson & Johnson antibiotic as a treatment against pneumonia Wednesday, despite serious concerns about how the company studied the drug.READ MORE
Jul 16, 2008 4:19PM
Keywords: JNJ, THRX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +7.80 54.77
GILEAD SCIENCES -16.80 42.46
CELGENE CORPORA -26.90 47.82
GENENTECH INC -4.90 71.80
GENZYME CORPORA -28.20 57.70